Before Alexander Fleming discovered penicillin in 1928 the rich "blue bloods" were simply raised with silver spoons. By 1930 the German biochemist Domagk had created the first commercial sulfonamide antibiotic called Prontosil. Within a few years it was noted that antimicrobial resistant bacteria that survived antibiotic treatment were becoming more and more common, thus making available antibiotics ineffective over time. The race was on for Pharmaceutical firms to develop new and stronger antibiotics (1600 antibiotics were developed) but as fast as they could roll out new products the bacteria would morph into superbugs. Bacteria is now in the lead as there are very few novel antibiotics under development but the race has not yet been lost thanks to our team.
Our Biochemist, Physicists and silver specialist have worked diligently in Europe for well over a decade to solve the problems that have kept silver from being a commercially viable solution for the augmentation of antibiotics. Yes, Augmentation! It is our team's desire to illustrate to the world and to the Pharmaceutical Industry that AMR2050 challenge can only be won together as a team. Our aim is to present tested and market ready products to remove antibiotics where possible to avoid introducing them to bacteria until required for human needs.Although our material can add-value to any product were inferior ionic wet-chemistry silver nano particles are currently used the focus for SVde Inc. (SanoVenture) is in areas that will have the greatest and most immediate impact on forestalling antimicrobial resistance. Food Safety is of foremost concern because as the world's population grows so does the risk of spreading resistant bacterial. We have conducted extensive research and validation testing that demonstrates how our material eliminates the need for antibiotics in the poultry industry at a reduced cost while allowing the chicken to grow 10% larger in comparison to the control group raised without the protection of our nano material. We also have materials ready for testing that would significantly alter how burns and open wounds are treated successfully (we offered Johnson & Johnson an opportunity to test this but they declined due to NIH). Our materials are being used successfully on some specialty combat boots for the EU and NATO and other textiles have withstood over 6000 wash cycles. Our sister spin-out nanoEffekt has made both silver and copper nanowires and envisions a future where we can 3d print integrated circuits for medically implanted devices coated with SanoVenture protective coatings that will not react with the body.
For sanoVenture #missionAMR is our vision of forestalling AMR2050 by serving an ounce of prevention before a pound of cure is needed. Of course we can produce wet-chemistry AgNP (pretty easy for the amepox team) products but that will only give us the same results as the hundreds of "silver" based antimicrobial products on the market today.
Most companies don't bother maximizing effective surface area because they are not capable of making particles smaller than 100nm (not even with wet-chemistry which is not so easy at sub 50nm). For us the challenge, which took us over a decade to overcome, was how to totally eliminate acid from the manufacturing process so that we would not be limited to only ionic silver. Once we developed the required equipment the next task was to make the silver crystalline so that it would not have a chemical reaction with humans or livestock. The proprietary manufacturing process and resultant materials are quite different from any AgNP the world has ever seen. Our material is so unique and different that we don't expect anyone to take our word for it. Simply purchase a sample of our acid-free crystalline AgNP and have a qualified laboratory test it against the best alternative material you can think of. We are so certain of the results that we'll gladly refund you the cost of the sample once you publish the findings in an open forum.
What have you got to lose? If we're wrong we'll suffer the embarrassment and our business will fail as a consequence. If we are right you'll have an opportunity to discuss with us your level of cooperation and your potential profits from being our partner in the fight against antimicrobial resistance.
We will address the Food Safety Vertical with multiple parallel COA; sanoPoultry is fully tested and impact investor ready. sanoWINE is currently testing our material as an alternative to adding SulferDioxide (SO?) during fermentation and bottling. sanoPAK is experimenting with the packing of highly perishable bacteria vulnerable products like meat and seafood. Varnish for canned food are being tested.
We will address the Transportation Vertical with the assistance of several partners who have unique and specific experience in the Cruiseline, Airline and Rail-line sectors along with experts in the facility management of hospitals and office buildings where large numbers of people gather with the potential of cross contamination spread via surface areas. Inks and injection moldable resins are in now being tested.
We will penetrate the Medical Vertical through our military relationships developed over decades of war fighting. As a Service-Disabled Veteran-Owned Small Businesses we will look for opportunities on FedBizOp to partner with industry to solve issues on the battlefield that will translate to the domestic hospital setting, treatment facilities and consumer products like salves and bandages. Coatings for the sanitizing of operatories are being tested.
Textiles vertical is interesting in that it is of high concern to individuals and of little consequence in the scheme of reducing the risk of antimicrobial resistance. It is also the segment where we expect to encounter numerous copycats claiming similar results with absolutely zero factual validation. We're focused on products that may come in contact with skin that may have healing wounds or areas of easy bacteria absorption by the body.